Comparison of Pneumonitis Rates and Severity in Patients With Lung Cancer Treated by Immunotherapy, Radiotherapy, and Immunoradiotherapy

Introduction Radiation pneumonitis (RP) is a common dose-limiting toxicity of radiotherapy to the chest in lung cancer patients. Similarly, the revolutionary use of immune checkpoint inhibitors (ICIs) to treat lung cancer can be complicated by immune-related adverse events (irAEs), particularly chec...

Descripción completa

Detalles Bibliográficos
Autores principales: Aiad, Mina, Fresco, Kayla, Prenatt, Zarian, Tahir, Ali, Ramos-Feliciano, Karla, Stoltzfus, Jill, Harmouch, Farah, Wilson, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167438/
https://www.ncbi.nlm.nih.gov/pubmed/35677739
http://dx.doi.org/10.7759/cureus.25665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167438/
https://www.ncbi.nlm.nih.gov/pubmed/35677739
http://dx.doi.org/10.7759/cureus.25665

Ejemplares similares